Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Ocean Biomedical, Inc. OCEA
$5.84
+$0.01 (0.17%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
202755120.00000000
-
week52high
26.60
-
week52low
3.06
-
Revenue
0
-
P/E TTM
-12
-
Beta
0.00000000
-
EPS
-0.04000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 мая 2023 г. в 04:00
Описание компании
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии